dexamethasone,lenalidomide,bortezomib
takeda
['multiple myeloma', 'determination']
starting now at #asco22 - plenary session by paul richardson, md, of dana-farber cancer institute discussing determination trial in multiple myeloma. 
News reporter turned healthcare storyteller. #RareDisease and #FoodAllergy advocate and coffee addict! @DanaFarber #7News alum. Tweets are my own.